$EXEL news
The latest EXEL stock news: headlines, filings, AI summaries and sentiment for $EXEL, updated around the clock.
- Exelixis Reports Strong Q3 2026 Growth Driven by Cabozantinib Sales
- EXELIXIS, INC. - 10-Q Filing
- EXELIXIS, INC. - 8-K Filing
- Exelixis Prepares for Zanza Launch Amid Slower-than-Expected NET Growth
- Exelixis Stock Falls After FDA Delays Approval of New Colon Cancer Treatment
- EXELIXIS, INC. - 8-K Filing
- Exelixis Stock Hits Record High Amid Cancer Treatment Momentum
- EXELIXIS, INC. - 8-K Filing
- Exelixis Reports Q1 2026 Earnings with Strong Cabozantinib Performance